You can buy or sell ZYNE and other stocks, options, ETFs, and crypto commission-free!
Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on research and development of rare and near-rare neuropsychiatric conditions. Read More It offers Zygel product which formulated as a permeation-enhanced gel for transdermal delivery. The company was founded by Audra L. Stinchcomb on January 31, 2007 and is headquartered in Devon, PA.
52 Week High
52 Week Low
— per share
Expected May 6, Pre-Market